Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
European Journal of Clinical Pharmacology|May 25, 2020
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trialsCinzia Dello Russo, Natalia Cappoli, Pierluigi Navarra
Annali Dell'Istituto Superiore Di Sanita|July 10, 2024
Compassionate drug uses in Italy. Analysis at single-center levelDaniela Pilunni, Maria Erica Blandino, Pierluigi Navarra
Peptides|October 2, 2010
Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatinAlessandro Capuano, Diego Currò, Pierluigi Navarra, et al.
Neurochemistry International|March 11, 2017
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigmEmilia Laudati, Diego Currò, Pierluigi Navarra, et al.
Experientia Supplementum (2012)|February 15, 2022
Monoclonal Antibodies to CTLA-4 with Focus on IpilimumabGrazia Graziani, Lucia Lisi, Lucio Tentori, et al.
The Journal of Headache and Pain|October 22, 2020
A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMABGiuseppe Tringali, Catello Vollono, Paolo Calabresi, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 7, 2015
The free fractions of circulating docosahexaenoic acid and eicosapentenoic acid as optimal end-point of measure in bioavailability studies on n-3 fatty acidsClaudia Scarsi, Ann Levesque, Lucia Lisi, et al.
Pageof 15